STEPHANIE MARTINS: Open Payments
NPI 1346904539 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$398 in 17 payments from 9 companies in 2025. Trend: 2023 $246 · 2024 $23 · 2025 $398
Food & beverage: $398
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 4 | $109 |
| ABBVIE INC. | 4 | $88 |
| UCB, Inc. | 1 | $44 |
| Janssen Biotech, Inc. | 2 | $40 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $30 |
| Arcutis Biotherapeutics, Inc. | 2 | $28 |
| Amgen Inc. | 1 | $26 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
| Galderma Laboratories, L.P. | 1 | $16 |
Products named: DUPIXENT, SKYRIZI, Bimzelx, TREMFYA, Winlevi, Zoryve, OTEZLA, COSENTYX.
Industry payments across AZ — which companies pay providers there.
